PA
Procyon Advisors Portfolio holdings
AUM
$1.06B
1-Year Return
19.43%
This Quarter Return
+10.23%
1 Year Return
+19.43%
3 Year Return
+67.94%
5 Year Return
+105.49%
10 Year Return
–
AUM
$1.06B
AUM Growth
-$588M
(-36%)
Cap. Flow
-$737M
Cap. Flow
% of AUM
-69.78%
Top 10 Holdings %
Top 10 Hldgs %
27.07%
Holding
612
New
23
Increased
80
Reduced
335
Closed
154
Top Buys
Top Sells
| 1 |
NVIDIA
NVDA
|
$35.8M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$33M |
| 3 |
Microsoft
MSFT
|
$32.6M |
| 4 |
Meta Platforms (Facebook)
META
|
$28.5M |
| 5 |
Amazon
AMZN
|
$25.8M |
Sector Composition
| 1 | Technology | 17.65% |
| 2 | Financials | 7.7% |
| 3 | Consumer Discretionary | 6.22% |
| 4 | Industrials | 4.96% |
| 5 | Communication Services | 4.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
VanEck Preferred Securities ex Financials ETF
PFXF
$1.96B
| $377K | 0.04% |
21,992
-1,510
| -6% | -$25.9K |
|
327
iShares Fallen Angels USD Bond ETF
FALN
$1.87B
| $376K | 0.04% |
13,853
-572,235
| -98% | -$15.5M |
|
328
PPL Corp
PPL
$26.6B
| $375K | 0.04% |
11,058
-6,597
| -37% | -$224K |
|
329
Unilever
UL
$157B
| $371K | 0.03% |
6,072
-62,050
| -91% | -$3.8M |
|
330
Intel
INTC
$107B
| $371K | 0.03% |
16,562
-3,009
| -15% | -$67.4K |
|
331
iShares Morningstar Mid-Cap ETF
IMCB
$1.18B
| $366K | 0.03% |
4,594
+7
| +0.2% | +$558 |
|
332
Peloton Interactive
PTON
$3.23B
| $361K | 0.03% |
52,007
-2,505
| -5% | -$17.4K |
|
333
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.13B
| $361K | 0.03% |
7,968
-1,298
| -14% | -$58.8K |
|
334
Choice Hotels
CHH
$5.38B
| $360K | 0.03% |
2,841
+49
| +2% | +$6.22K |
|
335
TransUnion
TRU
$17.6B
| $358K | 0.03% |
4,063
-84
| -2% | -$7.39K |
|
336
Manhattan Associates
MANH
$12.9B
| $356K | 0.03% |
1,801
+535
| +42% | +$106K |
|
337
iShares US Healthcare ETF
IYH
$2.77B
| $353K | 0.03% |
6,250
-1,890
| -23% | -$107K |
|
338
CrowdStrike
CRWD
$105B
| $351K | 0.03% |
690
-1,432
| -67% | -$729K |
|
339
Zoetis
ZTS
$67.6B
| $351K | 0.03% |
2,253
-2,299
| -51% | -$359K |
|
340
Realty Income
O
$53.9B
| $349K | 0.03% |
6,065
-616
| -9% | -$35.5K |
|
341
iShares Biotechnology ETF
IBB
$5.79B
| $349K | 0.03% |
2,759
+430
| +18% | +$54.4K |
|
342
Boston Scientific
BSX
$159B
| $348K | 0.03% |
3,241
-1,524
| -32% | -$164K |
|
343
Schwab US Dividend Equity ETF
SCHD
$71.6B
| $347K | 0.03% |
13,076
-1,143
| -8% | -$30.3K |
|
344
Capital One
COF
$142B
| $346K | 0.03% |
1,628
-20,941
| -93% | -$4.45M |
|
345
AstraZeneca
AZN
$253B
| $340K | 0.03% |
4,862
-32,992
| -87% | -$2.31M |
|
346
Cencora
COR
$56.6B
| $340K | 0.03% |
1,132
-4,819
| -81% | -$1.45M |
|
347
Landstar System
LSTR
$4.57B
| $338K | 0.03% |
2,429
-256
| -10% | -$35.6K |
|
348
Emerson Electric
EMR
$74.8B
| $332K | 0.03% |
2,489
-2,804
| -53% | -$374K |
|
|
AAA
349
Alternative Access First Priority CLO Bond ETF
AAA
$42.5M
| $329K | 0.03% |
13,180
-1,948
| -13% | -$48.6K |
|
350
Carrier Global
CARR
$55.5B
| $329K | 0.03% |
4,489
-1,074
| -19% | -$78.6K |
|